$15.70
-0.77 (-4.68%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-53.13%
1Y
-34.80%
YTD
-46.74%
Open$16.29
Previous Close$16.47
Day High$17.50
Day Low$15.50
52W High$55.65
52W Low$9.20
Volume—
Avg Volume35.8K
Market Cap2.39B
P/E Ratio234.71
EPS$0.23
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$29.64
Below
SMA 200
$30.05
Below
RSI (14)
49.5
Neutral
Trend
Death Cross
Bearish
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.49M | 39.79M | 1.84B |
| Net Income | 21.09M | 26.51M | -354,337,532 |
| Profit Margin | 74.1% | 70.4% | -19.2% |
| EBITDA | 19.01M | 25.22M | -454,323,212 |
| Free Cash Flow | — | — | -249,462,362 |
| Rev Growth | -28.4% | -28.4% | +17.6% |
| Debt/Equity | — | — | 0.51 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |